Your browser doesn't support javascript.
loading
Long-term follow-up reveals a low persistence rate of abobotulinumtoxinA injections for idiopathic overactive bladder.
Baron, M; Aublé, A; Paret, F; Pfister, C; Cornu, J-N.
Affiliation
  • Baron M; Urology Department, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex 1, France. Electronic address: maximilienbaron@hotmail.com.
  • Aublé A; Urology Department, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex 1, France.
  • Paret F; Urology Department, Nantes University Hospital, 1, place Alexis-Ricordeau, 44000 Nantes, France.
  • Pfister C; Urology Department, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex 1, France.
  • Cornu JN; Urology Department, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex 1, France.
Prog Urol ; 30(12): 684-691, 2020 Oct.
Article in En | MEDLINE | ID: mdl-32891504

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Botulinum Toxins, Type A / Urinary Bladder, Overactive Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Prog Urol Journal subject: UROLOGIA Year: 2020 Document type: Article Country of publication: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Botulinum Toxins, Type A / Urinary Bladder, Overactive Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Prog Urol Journal subject: UROLOGIA Year: 2020 Document type: Article Country of publication: France